LIFERIVER(SH:688317) Xin Lang Cai Jing·2025-09-23 02:50Core Viewpoint - Zhijiang Biotech experienced a decline of 5.03% on September 23, with a stock price of 22.86 CNY per share and a total market capitalization of 4.393 billion CNY [1] Company Overview - Zhijiang Biotech, established on April 18, 2005, and listed on January 18, 2021, is located in Minhang District, Shanghai. The company specializes in the research, production, and sales of molecular diagnostic reagents and equipment [1] - The revenue composition of the company includes 86.47% from nucleic acid testing kits, 11.99% from other products, and 1.54% from molecular diagnostic instruments [1] Shareholder Information - Among the top ten circulating shareholders of Zhijiang Biotech, a fund under Rongtong Fund holds 1.5 million shares, unchanged from the previous period, representing 0.78% of the circulating shares. The estimated floating loss today is approximately 1.815 million CNY [2] - The Rongtong Health Industry Flexible Allocation Mixed A/B fund (000727) was established on December 25, 2014, with a current scale of 2.074 billion CNY. Year-to-date returns are 19.74%, ranking 4408 out of 8172 in its category, while the one-year return is 46.63%, ranking 3544 out of 7995 [2] Fund Manager Information - The fund manager of Rongtong Health Industry Flexible Allocation Mixed A/B is Wan Minyuan, who has been in the position for 9 years and 31 days. The total asset scale of the fund is 5.629 billion CNY, with the best return during his tenure being 155.09% and the worst being -17.06% [3]